How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

1,452 results for

Intrauterine Growth Retardation

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

161. Heat shock protein 70 is upregulated in the intestine of intrauterine growth retardation piglets (PubMed)

Heat shock protein 70 is upregulated in the intestine of intrauterine growth retardation piglets The objective of this study is to investigate the expression and distribution of heat shock protein 70 (Hsp70) in the intestine of intrauterine growth retardation (IUGR) piglets. Samples from the duodenum, prejejunum, distal jejunum, ileum, and colon of IUGR and normal-body-weight (NBW) piglets were collected at birth. The results indicated that the body and intestine weight of IUGR piglets were

Full Text available with Trip Pro

2009 Cell stress & chaperones

162. Maternal Serum Angiopoietin-1 and -2 and Tie-2 in Early Pregnancy Ending in Preeclampsia or Intrauterine Growth Retardation. (PubMed)

Maternal Serum Angiopoietin-1 and -2 and Tie-2 in Early Pregnancy Ending in Preeclampsia or Intrauterine Growth Retardation. The antiangiogenic growth factor angiopoietin-2 (Ang-2) antagonizes, whereas angiopoietin-1 (Ang-1) activates the endothelial cell-specific tyrosine kinase receptor-2 (Tie-2). In preeclampsia, circulating concentrations of Ang-1 are increased and those of Ang-2 and Tie-2 are decreased.We wanted to study whether maternal serum concentrations of Ang-1, Ang-2, and Tie-2 (...) are altered at gestational wk 12-15 or 16-20 in women with subsequent preeclampsia or intrauterine growth retardation (IUGR).This was a case-control study.The study was conducted in Helsinki University Central Hospital, a tertiary referral center.This study comprised 124 pregnant women, of whom 49 developed preeclampsia and 16 gave birth to infants with IUGR, and 59 healthy women served as controls.Serum concentrations of Ang-1, Ang-2, and Tie-2 were assessed by ELISA. Data were combined with our earlier

Full Text available with Trip Pro

2009 Journal of Clinical Endocrinology and Metabolism

163. Severe Intrauterine Growth Retardation: Developmental Newborn Intensive Care Unit (NICU) Care

Severe Intrauterine Growth Retardation: Developmental Newborn Intensive Care Unit (NICU) Care Severe Intrauterine Growth Retardation: Developmental Newborn Intensive Care Unit (NICU) Care - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one (...) or more studies before adding more. Severe Intrauterine Growth Retardation: Developmental Newborn Intensive Care Unit (NICU) Care The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT00914108 Recruitment Status : Completed First Posted : June 4, 2009 Last Update Posted : June 4, 2009 Sponsor: Boston

2009 Clinical Trials

164. Dental and Oral Finding in Israeli Children With Past Intrauterine Growth Retardation (IUGR)

Dental and Oral Finding in Israeli Children With Past Intrauterine Growth Retardation (IUGR) Dental and Oral Finding in Israeli Children With Past Intrauterine Growth Retardation (IUGR) - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more (...) studies before adding more. Dental and Oral Finding in Israeli Children With Past Intrauterine Growth Retardation (IUGR) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT00867542 Recruitment Status : Unknown Verified March 2009 by Hadassah Medical Organization. Recruitment status was: Not yet recruiting

2009 Clinical Trials

165. Epigenetics: intrauterine growth retardation (IUGR) modifies the histone code along the rat hepatic IGF-1 gene (PubMed)

Epigenetics: intrauterine growth retardation (IUGR) modifies the histone code along the rat hepatic IGF-1 gene Intrauterine growth restriction (IUGR) decreases serum insulin growth factor-1 (IGF-1) levels. IGF-1 is an epigenetically regulated gene that has two promoters, alternative exon 5 splicing, and multiple termination sites. The regulation of gene expression involves the whole gene, as evidenced by the aforementioned IGF-1 paradigm. We hypothesized that IUGR in the rat would affect

Full Text available with Trip Pro

2009 The FASEB Journal

166. Neonatal exendin-4 treatment reduces oxidative stress and prevents hepatic insulin resistance in intrauterine growth-retarded rats (PubMed)

Neonatal exendin-4 treatment reduces oxidative stress and prevents hepatic insulin resistance in intrauterine growth-retarded rats Intrauterine growth retardation (IUGR) has been linked to the development of type 2 diabetes in adulthood. We have developed an IUGR model in the rat whereby the animals develop diabetes later in life. Previous studies demonstrate that administration of the long-acting glucagon-like-peptide-1 agonist, exendin-4, during the neonatal period prevents the development

Full Text available with Trip Pro

2009 American Journal of Physiology - Regulatory, Integrative and Comparative Physiology

167. Maternal serum endostatin at gestational weeks 16-20 is elevated in subsequent pre-eclampsia but not in intrauterine growth retardation. (PubMed)

Maternal serum endostatin at gestational weeks 16-20 is elevated in subsequent pre-eclampsia but not in intrauterine growth retardation. Endostatin, an important anti-angiogenic factor produced by endothelial cells, is elevated in established pre-eclampsia. We measured maternal serum endostatin concentrations in early pregnancy associated with later pre-eclampsia and intrauterine growth retardation (IUGR).Retrospective case-control study.University Central Hospital.Serum samples were collected

2009 Acta Obstetricia et Gynecologica Scandinavica

168. Candidate placental biomarkers for intrauterine alcohol exposure (PubMed)

Candidate placental biomarkers for intrauterine alcohol exposure Fetal alcohol spectrum disorder (FASD) is a leading cause of nongenetic mental retardation and other neurodevelopmental deficits. Earlier diagnosis of FASD would greatly improve prognosis for individuals and families affected by this disorder. Here, we identify candidate placental biomarkers in an animal model of FASD that recapitulates many aspects of human FASD.Pregnant Sprague-Dawley (SD) females were assigned to 1 of 3 diet (...) of intrauterine growth restriction (IUGR) markers Igf-2, Phlda2, and Cdkn1c were altered similarly in PF and E dams.We propose the specific pattern of increased Dio3 and decreased TRα1 and GR protein levels in the placenta as selective biomarker for intrauterine alcohol exposure.Copyright © 2010 by the Research Society on Alcoholism.

Full Text available with Trip Pro

2010 Alcoholism, clinical and experimental research

170. The Combined Use of Ultrasound and Fetal Magnetic Resonance Imaging for a Comprehensive Fetal Neurological Assessment in Fetal Congenital Cardiac Defects

of the semicircular canals in CHARGE syndrome (a condition composed of the following features: coloboma of the eye, heart defects, atresia choanae, growth retardation, genital and/or urinary abnormalities, and ear abnormalities and hearing impairment). Larger, long‐term studies are needed to appreciate the importance of obtaining antenatal information about not only overt abnormalities but quantifiable deviations in brain development alongside diagnostic accuracy in CHD, with respect to counselling, birth (...) . , , Furthermore, studies on fetuses incorporating magnetic resonance imaging (MRI), magnetic resonance spectroscopy and diffusion tension imaging (DTI) have revealed abnormalities of brain microstructure and metabolism before birth, as well as shortly after birth and before surgery. The origin of these changes is almost certainly multifactorial, with congenital brain abnormalities, intrauterine haemodynamic alterations and acquired brain injury all implicated. At present, the correlation of fetal neurological

2019 Royal College of Obstetricians and Gynaecologists

171. Antiplatelet and anticoagulant agents for primary prevention of thrombosis in individuals with antiphospholipid antibodies. (PubMed)

Antiplatelet and anticoagulant agents for primary prevention of thrombosis in individuals with antiphospholipid antibodies. Antiphospholipid syndrome (APS) is an autoimmune disease characterised by the presence of antiphospholipid (aPL) antibodies that have prothrombotic activity. Antiphospholipid antibodies are associated with an increased risk of pregnancy complications (recurrent miscarriage, premature birth, intrauterine growth retardation) and thrombotic events (both arterial and venous

2018 Cochrane

172. Overview of pregnancy complications

=bestpractice.com and illicit drug use. Sequelae include intrauterine growth restriction and premature delivery. Hydatidiform moles are chromosomally abnormal pregnancies that have the potential to become malignant (gestational trophoblastic neoplasia). Gestational trophoblastic disease (GTD) includes tumours of fetal tissues, including hydatidiform moles, arising from placental trophoblasts. The most common presenting symptom is vaginal bleeding and patients typically present in the first trimester (...) ) progress to actual labour and delivery. The remainder of pre-term birth is due to reasons for early delivery, most commonly because of pre-eclampsia and intrauterine growth restriction. Breech presentation in pregnancy occurs when a baby presents with the buttocks or feet rather than the head first (cephalic presentation) and is associated with increased morbidity and mortality for both the mother and the baby. It is common in early pregnancy and decreases with advancing gestational age, as most babies

2018 BMJ Best Practice

173. Syphilis infection

or stillbirth (congenital syphilis) premature labour and intrauterine growth retardation (congenital syphilis) neonatal skin rash (congenital syphilis) tibial bowing (congenital syphilis) craniofacial malformation (congenital syphilis) tooth abnormalities (congenital syphilis) necrotising funisitis (congenital syphilis) mouth ulcer asymptomatic (latent syphilis) tremor headache meningismus eye pain hearing loss seizures peripheral oedema jaundice peripheral neuropathy areflexia angina dyspnoea organomegaly

2018 BMJ Best Practice

174. Disorders of infant feeding

pulmonary infections and wheeze coughing or retching at meal times posture changes during feeds atopic features apparent life-threatening event (ALTEs) drooling ankyloglossia (tongue-tie) features of genetic conditions abnormal cardiorespiratory signs age <1 year prematurity intrauterine growth retardation developmental delay anatomical abnormalities of the oropharynx post-surgical correction of oropharyngeal or GI abnormalities Diagnostic investigations trial of hypoallergenic feed oesophageal 24-hour (...) the requirements for healthy growth in the long term. Failure to thrive may be a consequence of unresolved feeding problems of any aetiology. Aetiologies are often complex and multifactorial, and are best managed by a multidisciplinary team. Causes include anatomical, neuromuscular/neurodevelopmental, immunological, physiological, and behavioural factors. Diagnosis is usually clinical, with a consistent history supported by dietetic assessment. Complementary diagnostic tests and subsequent management

2018 BMJ Best Practice

175. Overview of pregnancy complications

=bestpractice.com and illicit drug use. Sequelae include intrauterine growth restriction and premature delivery. Hydatidiform moles are chromosomally abnormal pregnancies that have the potential to become malignant (gestational trophoblastic neoplasia). Gestational trophoblastic disease (GTD) includes tumours of fetal tissues, including hydatidiform moles, arising from placental trophoblasts. The most common presenting symptom is vaginal bleeding and patients typically present in the first trimester (...) ) progress to actual labour and delivery. The remainder of pre-term birth is due to reasons for early delivery, most commonly because of pre-eclampsia and intrauterine growth restriction. Breech presentation in pregnancy occurs when a baby presents with the buttocks or feet rather than the head first (cephalic presentation) and is associated with increased morbidity and mortality for both the mother and the baby. It is common in early pregnancy and decreases with advancing gestational age, as most babies

2018 BMJ Best Practice

176. Toxoplasmosis

have spread through the placenta to a fetus, T gondii rapidly travels to tissues and organs where it encysts and remains permanently. Infection in humans is life-long and often asymptomatic, unless a patient becomes immunosuppressed. History and exam presence of risk factors chorioretinitis focal neurological deficit blurry vision slurred speech headache unsteady gait confusion fever lymphadenopathy fetal microcephaly fetal intracranial calcification fetal hydrocephalus fetal intrauterine growth (...) retardation seizure malaise hepatitis pneumonitis myocarditis immunosuppression exposure during pregnancy residence in a high-risk area ingestion of undercooked or raw meat exposure to cat faeces heavy exposure to soil ingestion of unwashed unpeeled raw fruits and vegetables occupational exposure Diagnostic investigations anti-Toxoplasma IgG (serum) anti-Toxoplasma IgM (serum) CT (with IV contrast) or MR imaging of brain anti-Toxoplasma IgA (serum) anti-Toxoplasma IgE (serum) Toxoplasma-specific IgG

2018 BMJ Best Practice

177. Practice guideline: joint CCMG-SOGC recommendations for the use of chromosomal microarray analysis for prenatal diagnosis and assessment of fetal loss in Canada

a single structural defect is seen in association with other non-structural ultrasound findings, the frequency of pathogenic CMA results is higher, especially with intrauterine growth retardation or overgrowth (13.6%) or abnormal amni- otic fluid volume (9.1%). 11 Increased nuchal translucency (NT) =3.5 mm, or >99 percen- tile, is associated with increased risk of fetal aneuploidy as well as increased risk of certain syndromes and other structural defects. 13 A recent meta-analysis of the use of CMA (...) of chromosomal microarray analysis (in addition to any other relevant diagnostic testing) is recommended in cases with multiple fetal anomalies identified by a comprehensive obstetric ultrasound (II-1A). Other diagnostic testing may include specific single gene, multigene panels or other genetic tests if the pattern of anomalies suggests a specific genetic condition not identified by array (II-2 A). B. Single structural defects in association with other abnormal ultrasound findings (eg, intrauterine growth

2018 CPG Infobase

178. Cytomegalovirus Infection in Pregnancy

, petechiae, jaundice, chorioretinitis, thrombocytopenia and anemia, and long-term sequelae consist of sensorineural hearing loss, mental retardation, delay of psychomotor development, and visual impairment. These guidelines provide a framework for diagnosis and management of suspected CMV infections. Evidence Medline was searched for articles published in English from 1966 to 2009, using appropriate controlled vocabulary (congenital CMV infection) and key words (intrauterine growth restriction (...) or . Click to view the full text on ScienceDirect. Figures Figure Algorithm for prenatal diagnosis of congenital CMV Abstract Objectives To review the principles of prenatal diagnosis of congenital cytomegalovirus (CMV) infection and to describe the outcomes of the affected pregnancies. Outcomes Effective management of fetal infection following primary and secondary maternal CMV infection during pregnancy. Neonatal signs include intrauterine growth restriction (IUGR), microcephaly, hepatosplenomegaly

2018 Society of Obstetricians and Gynaecologists of Canada

179. ESC/ESH Management of Arterial Hypertension

Vascular endothelial growth factor WUCH White-coat uncontrolled hypertension 1 Preamble Guidelines summarize and evaluate available evidence with the aim of assisting health professionals in selecting the best management strategies for an individual patient with a given condition. Guidelines and their recommendations should facilitate decision making of health professionals in their daily practice. However, the final decisions concerning an individual patient must be made by the responsible health

Full Text available with Trip Pro

2018 European Society of Cardiology

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>